Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi

Gordon, Stephen B.; Kanyanda, Stonard; Walsh, Amanda L.; Goddard, Kristy; Chaponda, Mas; Atkinson, Victoria; Mulwafu, Wakisa; Molyneux, Elizabeth M.; Zijlstra, Ed E.; Molyneux, Malcolm E.; Graham, Steve M.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi

Published Date:

Jun 2003

Source:

Emerg Infect Dis. 9(6):747-749.

[PDF-194.17 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Gordon, Stephen B. ; Kanyanda, Stonard ; Walsh, Amanda L. ; Goddard, Kristy ; Chaponda, Mas ; ... More ▼

Description:

Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	03-0020-F.gif	image/gif
	03-0020-F.jpg	image/jpeg
	03-0020.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Invasive Streptococcus pneumoniae in Children, Malawi, 2004–2006

Personal Author:

Cornick, Jennifer E.; Everett, Dean B.; Broughton, Caroline; Denis, Brigitte B.; Banda, Daniel L.; Carrol, Enitan D.; Parry, Christopher M.;

Published Date:

Jun 2011

Source:

Emerg Infect Dis. 17(6):1107-1109.

Description:

Of 176 invasive Streptococcus pneumoniae isolates from children in Malawi, common serotypes were 1 (23%), 6A/B (18%), 14 (6%), and 23F (6%). Coverage with the 7-valent pneumococcal conjugate vaccine (PCV) was 39%; PCV10 and PCV13 increased coverage t...

File Type:

[PDF - 156.51 KB]
The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1

Personal Author:

Cornick, Jennifer E.; Tastan Bishop, Özlem; Yalcin, Feyruz; Kiran, Anmol M.; Kumwenda, Benjamin; Chaguza, Chrispin; Govindpershad, Shanil; Ousmane, Sani; Senghore, Madikay; du Plessis, Mignon; Pluschke, Gerd; Ebruke, Chinelo; McGee, Lesley; Sigaùque, Beutel; Collard, Jean-Marc; Bentley, Stephen D.; Kadioglu, Aras; Antonio, Martin; von Gottberg, Anne; French, Neil; Klugman, Keith P.; Heyderman, Robert S.; Alderson, Mark; Everett, Dean B.;

Corporate Authors:

for the PAGe consortium

Published Date:

Jan 09 2017

Source:

Vaccine. 2017; 35(6):972-980.

Description:

Serotype 1 is one of the most common causes of pneumococcal disease worldwide. Pneumococcal protein vaccines are currently being developed as an alternate intervention strategy to pneumococcal conjugate vaccines. Pre-requisites for an efficacious pne...

File Type:

[PDF - 1.64 MB]
INDIRECT EFFECTS OF 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST ADULT PNEUMOCOCCAL PNEUMONIA IN RURAL WESTERN KENYA

Personal Author:

Bigogo, Godfrey M.; Audi, Allan; Auko, Joshua; Aol, George O.; Ochieng, Benjamin J.; Odiembo, Herine; Odoyo, Arthur; Widdowson, Marc-Alain; Onyango, Clayton; Borgdorff, Martien W.; Feikin, Daniel R.; Carvalho, Maria da G; Whitney, Cynthia G.; Verani, Jennifer R.;

Published Date:

Nov 27 2019

Source:

Clin Infect Dis. 69(12):2177-2184

Description:

Background:Data on pneumococcal conjugate vaccine (PCV) indirect effects in low-income countries with high HIV burden are limited. We examined adult pneumococcal pneumonia incidence before and after 10-valent PCV introduction in Kenya in 2011.Methods...

File Type:

[PDF - 619.75 KB]
Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi

Personal Author:

Chaguza, Chrispin; Cornick, Jennifer E.; Andam, Cheryl P.; Gladstone, Rebecca A.; Alaerts, Maaike; Musicha, Patrick; Peno, Chikondi; Bar-Zeev, Naor; Kamng'ona, Arox W.; Kiran, Anmol M.; Msefula, Chisomo L.; McGee, Lesley; Breiman, Robert F.; Kadioglu, Aras; French, Neil; Heyderman, Robert S.; Hanage, William P.; Bentley, Stephen D.; Everett, Dean B.;

Published Date:

Jul 12 2017

Source:

Vaccine. 2017; 35(35Part B):4594-4602.

Description:

IntroductionPneumococcal infections cause a high death toll in Sub Saharan Africa (SSA) but the recently rolled out pneumococcal conjugate vaccines (PCV) will reduce the disease burden. To better understand the population impact of these vaccines, co...

File Type:

[PDF - 1.31 MB]
High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya

Personal Author:

Feikin, Daniel R; Jagero, Geoffrey; Aura, Barrack; Bigogo, Godfrey M; Oundo, Joseph; Beall, Bernard W; Karani, Angela; Morpeth, Susan; Njenga, M Kariuki; Breiman, Robert F;

Published Date:

Jun 23 2010

Source:

BMC Infect Dis. 2010; 10:186.

Description:

BackgroundAlthough causing substantial morbidity, the burden of pneumococcal disease among older children and adults in Africa, particularly in rural settings, is not well-characterized. We evaluated pneumococcal bacteremia among 21,000 persons ≥5 ...

File Type:

[PDF - 632.82 KB]